Los Angeles Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-137
| Closed | -$322K | – | 1413 |
|
|
2018
Q3 | $322K | Hold |
137
| – | – | ﹤0.01% | 1206 |
|
|
2018
Q2 | $471K | Sell |
137
-373
| -73% | -$1.28M | ﹤0.01% | 1152 |
|
|
2018
Q1 | $1.45M | Buy |
510
+164
| +47% | +$466K | 0.01% | 730 |
|
|
2017
Q4 | $890K | Buy |
+346
| New | +$890K | ﹤0.01% | 882 |
|
|
2016
Q3 | – | Sell |
-82
| Closed | -$251K | – | 1299 |
|
|
2016
Q2 | $251K | Buy |
+82
| New | +$251K | ﹤0.01% | 1102 |
|
|
2016
Q1 | – | Sell |
-81
| Closed | -$414K | – | 1209 |
|
|
2015
Q4 | $414K | Sell |
81
-18
| -18% | -$92K | ﹤0.01% | 900 |
|
|
2015
Q3 | $315K | Hold |
99
| – | – | ﹤0.01% | 1000 |
|
|
2015
Q2 | $396K | Sell |
99
-30
| -23% | -$120K | ﹤0.01% | 991 |
|
|
2015
Q1 | $516K | Buy |
+129
| New | +$516K | ﹤0.01% | 918 |
|